Sermorelin Peptide Therapy

Sermorelin is a synthetic peptide fragment of growth hormone-releasing hormone (GHRH). Researched as a way to support the body's own pulsatile growth hormone production.

Plain unbranded photo representing Sermorelin (GHRH 1-29) therapy at Menscape Bangkok
What Sermorelin may support

What Sermorelin may support

Sermorelin works by signaling the pituitary to release endogenous growth hormone, rather than introducing exogenous HGH. Studied for body composition, recovery, and sleep quality in adult deficiency contexts.

Eligibility depends on confirmed clinical indicators. Our team orders the appropriate labs and evaluates baseline IGF-1, hormone panel, and overall metabolic status before any protocol is started.

Patient experiences

Booked a full hormone panel first. The doctor only started Sermorelin after the labs confirmed it made sense. I appreciated that gating.

Henri, 52

Six months in. Sleep is genuinely better. The clinic checks IGF-1 quarterly and adjusted my dose once.

Marcus, 48

Wanted GH support without going onto HGH directly. Sermorelin felt like the right risk profile. Communication has been clear throughout.

David, 56

Our solutions for Weight‑Loss Management

What BPC-157 is studied for

Indications evaluated in research, listed in order of current evidence weight. Suitability is determined case-by-case.

Adult GH deficiency support

Sermorelin is researched specifically in adults with documented growth hormone insufficiency. Lab confirmation is required.

Adult GH deficiency support

Body composition

Studies suggest improvements in lean mass and reductions in fat mass over multi-month protocols.

Body composition

Sleep & recovery

GH release peaks during deep sleep; restoring pulsatile signaling may improve sleep architecture in deficient adults.

Sleep & recovery

Energy & vitality

Reported subjective improvements in daytime energy and exercise tolerance after 3 to 6 months.

Energy & vitality

What is Sermorelin?

Sermorelin is a synthetic peptide fragment of growth hormone-releasing hormone (GHRH). Researched as a way to support the body's own pulsatile growth hormone production.

What is Sermorelin?

How Sermorelin may work

Sermorelin mimics GHRH and signals the pituitary to release growth hormone in natural pulses. Because the body's feedback loops stay intact, the response is more physiological than exogenous HGH.

How Sermorelin may work

Who it may be evaluated for

Adults with confirmed GH insufficiency on labs (low IGF-1, supportive hormone panel) and goals around body composition, recovery, and sleep. Lab confirmation is mandatory.

Who it may be evaluated for

How Menscape prescribes Sermorelin

Baseline IGF-1 and metabolic panel are drawn first. If indicated, daily bedtime injection is started, with IGF-1 rechecked at 8 to 12 weeks to adjust dose.

How Menscape prescribes Sermorelin

Doctor-led evaluation

Every Sermorelin protocol starts with a full medical consultation and history review.

Licensed compounding pharmacy

Prescriptions are filled by a licensed compounding pharmacy partner, not over-the-counter.

Monthly monitoring

Follow-up consultations every four to six weeks to assess response and safety.

Research-informed positioning

We frame Sermorelin as a research-stage peptide and prescribe only when clinically appropriate.

Sermorelin questions

Is Sermorelin the same as HGH?

No. HGH is the hormone itself, taken exogenously. Sermorelin is a releasing peptide that stimulates your own pituitary, preserving the body's feedback loops.

How is Sermorelin administered?

Subcutaneous injection, typically once daily before bedtime to align with the natural GH pulse. Your doctor sets dose and duration.

Will I need bloodwork?

Yes. Baseline IGF-1, hormone panel, and metabolic markers are required before starting, and follow-up labs are part of the protocol.

Is Sermorelin FDA-approved?

Sermorelin has historical FDA approval for pediatric GH deficiency. Adult use is off-label and prescribed only when clinically appropriate.

What lab tests do you run before starting?

Baseline IGF-1, fasting glucose, lipid panel, thyroid function, and a hormone panel including testosterone. We do not prescribe Sermorelin without lab confirmation that the protocol is clinically justified.

Who should not use Sermorelin?

Patients with active or recent cancer, untreated pituitary disorders, severe sleep apnea, or known hypersensitivity. Pregnancy and breastfeeding are also contraindications.

Talk with our medical team about BPC-157

Talk with our medical
team about BPC-157
Talk with our medical team about BPC-157